埃多克萨班消除了人类全血中短暂的温度变化引起的高凝血能力
Anna Suzuki1, Satomi Hamada1,2, Ai Oono1
1Department of Cardiovascular Medicine Tokyo Medical and Dental University (TMDU) Tokyo Japan.
在医疗程序期间短暂的温度变化可能会增加血栓的风险. 作为抗凝剂的埃多克萨班在100 ng/mL或更高的度下有效地防止了这种温度诱导的高凝血.
科学领域:
- 心血管医学 心血管医学
- 血液学 血液学 血液学
- 生物医学工程 生物医学工程
背景情况:
- 血栓形成是射频和冷处理程序的关键并发症.
- 剥离过程中的极端温度可能会改变血液凝结能力.
- 研究热刺激对血液凝固的影响至关重要.
研究的目的:
- 为了确定短暂的温度变化对全血凝结能力的影响.
- 评估埃多克萨班能否抑制温度诱导的高凝血能力.
- 了解与剥离相关的血栓形成背后的机制.
主要方法:
- 来自健康受试者的全血样本经过热 (50°C) 和冷刺激 (-20°C).
- 组织因子和不同度的edoxaban被添加到血液样本中.
- 使用介电凝血计测量血液凝结能力,评估加速时间结束 (EAT).
主要成果:
- 热和冷刺激都显著缩短了EAT,这表明诱导了高凝血能力.
- 组织因子增强并延长了高凝血状态.
- 埃多克萨班证明了EAT的度依赖的增加,抑制了温度诱导的高凝血能力.
结论:
- 短暂的热刺激,无论是热还是冷,都会在全血中诱导高凝血.
- 在100 ng/mL及以上度的埃多克萨班有效地减轻了温度刺激的高凝血能力.
- 这些发现表明,埃多克萨班在预防与切除相关的血栓形成方面具有潜在的治疗作用.
更多相关视频
07:08Assessment of the Anticoagulant and Anti-inflammatory Properties of Endothelial Cells Using 3D Cell Culture and Non-anticoagulated Whole Blood
Published on: September 5, 2017
04:56Author Spotlight: Deciphering Coagulation Disorders in Traumatic Brain Injury Patients
Published on: August 4, 2023
相关概念视频
Anticoagulant Drugs: Vitamin K Antagonists and Direct Oral Anticoagulants
Warfarin, a prominent vitamin K antagonist family member, exerts its effect by inhibiting the enzyme VKORC1 (vitamin K epoxide reductase complex 1). By hindering this enzyme, warfarin...
Anticoagulant Drugs: Low-Molecular-Weight Heparins
Disorders of Hemostasis
Thromboembolic Disorders
Two factors primarily cause thromboembolic conditions.
Extrinsic and Intrinsic Pathways of Hemostasis
The Extrinsic Pathway
The extrinsic pathway of coagulation is typically initiated by tissue damage that exposes blood to tissue factor (TF), a protein released by the damaged tissue cells outside the blood vessels—this interaction with TF triggers biochemical reactions involving specific clotting factors. The key player here is Factor VII, which...
Factors Affecting Body Temperature
Factors may include:
Chronopharmacokinetics: Circadian Rhythms and Influence on Drug Response
The time of drug administration is an important factor to consider, as it can influence the toxic dose of a drug. For example, a study conducted by Prins et al. in 1997 examined the effects of the timing of...
